Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in
young children and elderly people. Although the virus was isolated in 1955, an effective …

In global terms, respiratory viral infection is a major cause of morbidity and mortality. Infancy,
in particular, is a time of increased disease susceptibility and severity. Early-life viral …

Human respiratory syncytial virus (RSV) is an enveloped, nonsegmented negative-strand
RNA virus of family Paramyxoviridae. RSV is the most complex member of the family in …

Human respiratory syncytial virus (RSV) is a ubiquitous pathogen that infects everyone
worldwide early in life and is a leading cause of severe lower respiratory tract disease in the …

Human respiratory syncytial virus (RSV) was first isolated in 1956 from a laboratory
chimpanzee with upper respiratory tract disease (for general reviews, see references 21, 57 …

Respiratory Syncytial Virus (RSV) is the commonest cause of severe respiratory infection in
infants, leading to over 3 million hospitalizations and around 66,000 deaths worldwide each …

Rationale: Respiratory syncytial virus (RSV) bronchiolitis causes significant infant mortality.
Bronchiolitis is characterized by airway epithelial cell (AEC) death; however, the mode of …

Respiratory syncytial virus (RSV) has eluded active vaccination efforts for more than five
decades and continues to cause substantial morbidity and mortality in infants, the …

Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract
disease in children< 2 years of age. Increased morbidity and mortality have been reported in …

ABSTRACT A wide variety of RNA viruses have been shown to produce proteins that inhibit
interferon (IFN) production and signaling. For human respiratory syncytial virus (RSV), the …